Endoscopy 2025; 57(08): C8
DOI: 10.1055/a-2571-2951
Correction

Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I–III pancreatic ductal adenocarcinoma

Authors

  • Thaninee Prasoppokakorn

    1   Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
  • Roongruedee Chaiteerakij

    1   Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
    2   Center of Excellence for Innovation and Endoscopy in Gastrointestinal Oncology, Faculty of Medicine, Chuallongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
  • Areeya Buntho

    1   Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
  • Praewphan Ingrungruanglert

    3   Center of Excellence in Stem Cell and Cell Therapy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
    4   Excellence Center for Stem Cell and Cell Therapy, King Chulalongkorn Memorial Hospital, Bangkok, Thailand (Ringgold ID: RIN176044)
  • Nipan Israsena

    3   Center of Excellence in Stem Cell and Cell Therapy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
    4   Excellence Center for Stem Cell and Cell Therapy, King Chulalongkorn Memorial Hospital, Bangkok, Thailand (Ringgold ID: RIN176044)
  • Wiriyaporn Rittitid

    1   Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
    2   Center of Excellence for Innovation and Endoscopy in Gastrointestinal Oncology, Faculty of Medicine, Chuallongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
  • Phonthep Angsuwatcharakon

    5   Anatomy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
  • Parit Mekaroonkamol

    1   Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
  • Pradermchai Kongkam

    1   Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
  • Rungsun Rerknimitr

    1   Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
    2   Center of Excellence for Innovation and Endoscopy in Gastrointestinal Oncology, Faculty of Medicine, Chuallongkorn University, Bangkok, Thailand (Ringgold ID: RIN65103)
Preview

10.1055/a-2535-7440

In the above-mentioned article Figure 3 has been corrected. Correct is for “Stage II” that 3 patients underwent chemotherapy. This was corrected in the online version on April 3, 2025.



Publikationsverlauf

Artikel online veröffentlicht:
03. April 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany